ABSTRACT- ADMINISTRATIVE CORE
The Administrative Core will coordinate the scientific and administrative activities of this IPCAVD Program,
ensuring that the Projects and Cores function well together. In particular, it will be responsible for managing the
program’s financial management, program management, and coordinating Projects and Cores through scientific
meetings and communications, as well as ensuring full financial and regulatory compliance. A primary activity
of the Core will be monitoring IPCAVD progress relative to milestones and measuring this progress against
available funding to ensure resources are used efficiently. As Specific Aims, the Core will provide overall
IPCAVD management, coordination and supervision of the Program (Aim 1), ensure timely financial accounting
and reporting (Aim 2), ensure compliance with all institutional, state, and federal research and cGMP guidelines
(Aim 3), develop and implement IPCAVD communication, publication, and data sharing plans (Aim 4), and
provide statistical support for all data analyses (Aim 5). The Core will coordinate an annual meeting with an
External Advisory Committee (EAC) that will review the progress of IPCAVD Projects and Cores, and with input
from the DAIDS Program Team, provide guidance for the Program’s direction. Core staff are part of a highly
experienced and integrated management team, which will enable immediate start-up and rapid progress.
This teamwork will accelerate advancement toward the Program’s goals, thus maximizing the opportunities to
positively impact HIV-1 vaccine research in humans.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAccountingAdvisory CommitteesAgreementAntibodiesAntigensB-LymphocytesBudgetsCell LineageClinical TrialsCommunicationDataData AnalysesData ProvenanceDevelopmentEnsureExpenditureExperimental DesignsFerritinFundingGoalsGood Manufacturing ProcessGrantGuidelinesHIV-1HIV-1 vaccineHumanHuman ResourcesIACUCImmune responseInfrastructureInstitutionInstitutional PolicyLeadMeasuresMonitorNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesOutcomeParticipantPhase I Clinical TrialsPoliciesPractice GuidelinesPreparationProductionProteinsProtocols documentationPublicationsRegulationReportingResearchResearch PersonnelResourcesRightsRiskSiteSupervisionTestingUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesVaccine ResearchVaccinesconflict resolutiondata managementdata sharingexpectationexperienceinterestmeetingsmembernanoparticlenext generation sequencingprogramsquality assurancesortasevaccine developmentvaccine platform
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
044387793
UEI
TP7EK8DZV6N5
Project Start Date
17-December-2021
Project End Date
30-November-2026
Budget Start Date
01-December-2024
Budget End Date
30-November-2025
Project Funding Information for 2025
Total Funding
$1,541,147
Direct Costs
$1,628,868
Indirect Costs
$955,125
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$1,541,147
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U19AI160546-04 8262
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U19AI160546-04 8262
Patents
No Patents information available for 5U19AI160546-04 8262
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U19AI160546-04 8262
Clinical Studies
No Clinical Studies information available for 5U19AI160546-04 8262
News and More
Related News Releases
No news release information available for 5U19AI160546-04 8262
History
No Historical information available for 5U19AI160546-04 8262
Similar Projects
No Similar Projects information available for 5U19AI160546-04 8262